Saple, D. G., Save, S., Kumar, D., & Sood, S. (2022). An open label, single arm, pilot study to evaluate the safety, tolerability, and efficacy of daily fluconazole 150 mg in subjects suffering from Tinea cruris and Tinea corporis [version 2; peer review: 1 approved with reservations, 1 not approved]. F1000 research, 11, 1446. https://doi.org/10.12688/f1000research.127138.2
Chicago-Zitierstil (17. Ausg.)Saple, Dattatray Gopal, Sushrut Save, Devesh Kumar, und Suneet Sood. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 2; Peer Review: 1 Approved with Reservations, 1 Not Approved]." F1000 Research 11 (2022): 1446. https://doi.org/10.12688/f1000research.127138.2.
MLA-Zitierstil (9. Ausg.)Saple, Dattatray Gopal, et al. "An Open Label, Single Arm, Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of Daily Fluconazole 150 Mg in Subjects Suffering from Tinea Cruris and Tinea Corporis [version 2; Peer Review: 1 Approved with Reservations, 1 Not Approved]." F1000 Research, vol. 11, 2022, p. 1446, https://doi.org/10.12688/f1000research.127138.2.